Opaleye Management as of June 30, 2023
Portfolio Holdings for Opaleye Management
Opaleye Management holds 47 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Acelyrin | 20.8 | $87M | 4.2M | 20.90 | |
| Harrow Health (HROW) | 17.2 | $72M | 3.8M | 19.04 | |
| Ocular Therapeutix (OCUL) | 7.1 | $30M | 5.8M | 5.16 | |
| Tela Bio (TELA) | 3.8 | $16M | 1.6M | 10.13 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.6 | $15M | 845k | 18.02 | |
| Keros Therapeutics (KROS) | 3.4 | $14M | 353k | 40.18 | |
| Biohaven (BHVN) | 3.1 | $13M | 540k | 23.92 | |
| Rhythm Pharmaceuticals (RYTM) | 2.9 | $12M | 735k | 16.49 | |
| Ideaya Biosciences (IDYA) | 2.3 | $9.8M | 415k | 23.50 | |
| Morphosys Sponsored Ads (MOR) | 2.2 | $9.0M | 1.2M | 7.47 | |
| Vaxcyte (PCVX) | 2.1 | $8.8M | 177k | 49.94 | |
| Eton Pharmaceuticals (ETON) | 1.9 | $8.0M | 2.3M | 3.49 | |
| Geron Corporation (GERN) | 1.8 | $7.5M | 2.4M | 3.21 | |
| Marinus Pharmaceuticals Com New | 1.6 | $6.8M | 625k | 10.86 | |
| Kalvista Pharmaceuticals (KALV) | 1.5 | $6.5M | 720k | 9.00 | |
| Protara Therapeutics Com Stk (TARA) | 1.5 | $6.4M | 2.7M | 2.39 | |
| Edgewise Therapeutics (EWTX) | 1.5 | $6.3M | 815k | 7.75 | |
| Cymabay Therapeutics | 1.5 | $6.2M | 567k | 10.95 | |
| Urogen Pharma (URGN) | 1.4 | $5.9M | 570k | 10.35 | |
| Theravance Biopharma (TBPH) | 1.3 | $5.6M | 544k | 10.35 | |
| Theseus Pharmaceuticals | 1.3 | $5.6M | 598k | 9.33 | |
| ACADIA Pharmaceuticals (ACAD) | 1.2 | $5.2M | 217k | 23.95 | |
| Intellia Therapeutics (NTLA) | 1.2 | $4.9M | 120k | 40.78 | |
| Liquidia Corporation Com New (LQDA) | 1.1 | $4.5M | 571k | 7.85 | |
| Larimar Therapeutics (LRMR) | 1.0 | $4.4M | 1.4M | 3.13 | |
| Cytokinetics Com New (CYTK) | 1.0 | $4.2M | 130k | 32.62 | |
| Trevi Therapeutics (TRVI) | 1.0 | $4.1M | 1.7M | 2.39 | |
| Gossamer Bio (GOSS) | 1.0 | $4.0M | 3.4M | 1.20 | |
| 4d Molecular Therapeutics In (FDMT) | 1.0 | $4.0M | 222k | 18.07 | |
| Nyxoah S A SHS (NYXH) | 0.9 | $3.6M | 445k | 8.01 | |
| Edap Tms S A Sponsored Adr (EDAP) | 0.8 | $3.5M | 380k | 9.22 | |
| Karyopharm Therapeutics | 0.8 | $3.2M | 1.8M | 1.79 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $3.0M | 421k | 7.04 | |
| Spectrum Pharmaceuticals Com New (STXS) | 0.7 | $3.0M | 3.1M | 0.96 | |
| Astria Therapeutics (ATXS) | 0.6 | $2.5M | 305k | 8.33 | |
| Codexis (CDXS) | 0.5 | $1.9M | 675k | 2.80 | |
| Fortress Biotech | 0.4 | $1.8M | 3.3M | 0.55 | |
| Sutro Biopharma (STRO) | 0.3 | $1.4M | 307k | 4.65 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $1.4M | 275k | 5.05 | |
| Tracon Pharmaceuticals Com New | 0.3 | $1.4M | 4.8M | 0.29 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 0.3 | $1.1M | 653k | 1.62 | |
| Jounce Therapeutics | 0.2 | $918k | 670k | 1.37 | |
| Verastem Com New (VSTM) | 0.2 | $759k | 102k | 7.44 | |
| Xoma Corp Del Com New (XOMA) | 0.1 | $595k | 275k | 2.16 | |
| Igm Biosciences (IGMS) | 0.1 | $586k | 64k | 9.23 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $474k | 144k | 3.30 | |
| Kezar Life Sciences | 0.1 | $242k | 99k | 2.45 |
